ZIP-1642

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameZIP-1642

Drug Alias Namedual-antigen self-amplifying RNA SARS-CoV-2 vaccine ZIP-1642ZIP-1642

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesZiphius Vaccines NV

China Registration ClassN/A

Develop Information

Active CompaniesZiphius Vaccines NV

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A